Flagship Ventures Fund V, L.P. 13D and 13G filings for Sana Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:19 pm Sale | 2023-12-31 | 13G | Sana Biotechnology, Inc. SANA | Flagship Ventures Fund V, L.P. | 25,583,551 13.000% | -8,655,467 (-25.28%) | Filing |
| 2022-02-14 3:02 pm Purchase | 2021-12-31 | 13G | Sana Biotechnology, Inc. SANA | Flagship Ventures Fund V, L.P. | 34,239,018 18.100% | 34,239,018 (New Position) | Filing |